Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25767930

Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells

Author
KUZUMAKI, N1 2 ; SUZUKI, A3 ; OKANO, H. J1 ; YAMASHITA, J. K5 ; OKANO, H1 ; SUZUKI, T3 ; NARITA, M2 ; NARITA, M2 ; HOSOYA, T4 ; NAGASAWA, A2 ; IMAI, S2 ; YAMAMIZU, K5 ; MORITA, H6 ; NAGASE, H7 ; OKADA, Y1
[1] Department of Physiology, Keio University, School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo 160-8582, Japan
[2] Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
[3] Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
[4] Biological Systems Control Team Biomedicinal Information Research Center, Aomi 2-4-7, Koto-ku, Tokyo 135-0064, Japan
[5] Laboratory of Stem Cell Differentiation, Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
[6] Faculty of Pharmaceutical Sciences, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
[7] Laboratory of Medical Chemistry, School of Pharmacy, Kitasato University, Tokyo, Japan
Source

British journal of cancer. 2012, Vol 106, Num 6, pp 1148-1152, 5 p ; ref : 1/4 p

CODEN
BJCAAI
ISSN
0007-0920
Scientific domain
Medical oncology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
gefitinib non-small cell lung cancer κ-opioid receptor
Keyword (fr)
Agoniste Anticancéreux Cancer du poumon Cancérologie Carcinome non petite cellule bronchopulmonaire Glycogen synthase kinase-3β Géfitinib Homme Multiplication cellulaire Phosphorylation Récepteur opiacé κ Résistance traitement Anti-EGFR Cancer Dérivé de la quinazoline Enzyme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Protein-tyrosine kinase Transferases Tumeur maligne
Keyword (en)
Agonist Antineoplastic agent Lung cancer Cancerology non-small cell lung carcinoma Glycogen synthase kinase-3β Gefitinib Human Cell proliferation Phosphorylation κ Opioid receptor Treatment resistance Cancer Quinazoline derivatives Enzyme Tyrosine kinase inhibitor Enzyme inhibitor Respiratory disease Bronchus disease Lung disease Protein-tyrosine kinase Transferases Malignant tumor
Keyword (es)
Agonista Anticanceroso Cáncer del pulmón Cancerología Carcinoma no pequeňa célula bronchopulmonar Glycogen synthase kinase-3β Gefitinib Hombre Multiplicación celular Fosforilación Receptor opiáceo κ Resistencia tratamiento Cáncer Enzima Inhibidor tyrosine kinase Inhibidor enzima Aparato respiratorio patología Bronquio patología Pulmón patología Protein-tyrosine kinase Transferases Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R01 General aspects

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Discipline
Pharmacological treatments Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
25767930

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web